The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
Clinical trial NCT00872599 · COMPLETED
Trial details
- NCT number
- NCT00872599
- Sponsor
- Vanderbilt University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.